The purpose of this study is to determine the effect of nonpharmacologic group treatment for patients with secondary insomnia.

Condition	Intervention
Secondary Insomnia	Behavior: Education about sleep and sleep hygiene  Behavior: cognitive therapy  Behavior: Sleep restriction  Behavior: Relaxation techniques

Further study details as provided by Norwegian University of Science and Technology:

Primary Outcomes: Scores on rating scales for sleep quality
Secondary Outcomes: Scores on rating scales for depression, psychiatric symptom severity, and cognitive processing.
Expected Total Enrollment:  40

This study is a randomized controlled trial with 40 paitents with a psychiatric disorder and insomnia. The patients will be randimized into two groups of 20 patients. The first group recieve group therapy immediately, whereas the second group will be assigned to a waiting list control for five weeks before they also receive group therapy. The patients will be given six sessions of group therapy, twice a week for three weeks. The main topics will be: education about sleep and sleep hygiene, cognitive therapy, stimulus control, sleep restriction, and relaxation techniques.

Ages Eligible for Study:  18 Years and above,  Genders Eligible for Study:  Both

Accepts Healthy Volunteers

Criteria

Inclusion Criteria:

• Insomnia secondary to a primary psychiatric disorder

Exclusion Criteria:

• substance abuse, psychotic symptoms, suicidal intentions, severe organic disorder or psychiatric disorder where sleep restriction is not adviced, organic sleep disorder.

Please refer to this study by ClinicalTrials.gov identifier  NCT00235365

Knut Langsrud, Psychiatrist      +4773864500    knut.langsrud@ntnu.no
Bjarne Hansen, Psychologist      +4773864604    bjarne.hansen@ntnu.no

Norway
      Norwegian University of Science and Technology, Institute of Neuroscience, Trondheim,  Norway

Study chairs or principal investigators

Gunnar Morken, PhD MD,  Principal Investigator,  Norwegian University of Science and Technology   

Study ID Numbers:  S2005.2.gr
Last Updated:  December 8, 2005
Record first received:  October 7, 2005
ClinicalTrials.gov Identifier:  NCT00235365
Health Authority: Norway: Norwegian Social Science Data Services
ClinicalTrials.gov processed this record on 2006-01-10